Varda Biotech Private Limited - Due diligence report

A 360° intelligence report on Varda Biotech Private Limited: trust score, financial health, credit view, compliance, directors, growth and d…

2001-12-04 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
View plans Plan
VB Varda Biotech Private Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Varda Biotech Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
71/100
Trust Score
Moderate

Varda Biotech Private Limited is assessed as Moderate with a Trust Score of 71/100. Varda Biotech Private Limited is an active private limited indian non-government company incorporated in 2001, operating in the Life Sciences sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.

Report generated on 14 Jul 2026 from the latest processed filings. Varda Biotech Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
71/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
63/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
45/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
30/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 30/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.

Charges position: 1 open (10.00 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India1 48.0 cr
Compliance Score: 63/100 Moderate
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: MCA.
  • Litigation present in 1 court forum(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
BALKRISHNA KRISHNA MURARI SHARMA 01234567 Director 01/04/2018 6 yrs Approved
PRASHANT SURESH DEVRUKHKAR 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 2 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 90
Growth signals & trust indicators
Operating for 24+ years.
Distress signals & risk flags
1 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence74/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment43/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 10.00 Lakh already registered.
  • Compliance gaps should be priced into terms.
Investor view54/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
31 Mar 2021
Share transfer (FY 2021)
27490.00000000 shares to Balkrishna Krishna Murari Sharma
Share transfer (FY 2021)
10.00000000 shares to Prashant Devrukhkar
23 Apr 2018
Director ceased
VINAY KUMAR AMBATI
30 Sep 2017
Director ceased
PRASHANT SURESH DEVRUKHKAR
08 Sep 2017
Director appointed
PRASHANT SURESH DEVRUKHKAR (Director)
22 Dec 2015
Director ceased
MANOHAR VISHWANATHAM BOMMANPAD
30 Sep 2015
Director ceased
BALKRISHNA KRISHNA MURARI SHARMA
10 Oct 2014
Director appointed
BALKRISHNA KRISHNA MURARI SHARMA (Director)
23 Apr 2014
Director ceased
VIJAY KUMAR AMBATI
17 Jan 2008
Charge created
State Bank Of India - 10.00 Lakh
04 Dec 2001
Incorporated
Registered with Roc Mumbai
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a majority stake as per the FY 2023 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Lablinks Biotech U33119KA1989PTC010439 Bangalore, Karnataka, India
Oxyflora Biotech Private Limited U01100DL2021PTC379978 Delhi, Delhi, India
Waybiond Biotech Private Limited U24239MH2021PTC358237 Palghar, Maharashtra, India
Insectika Biotech Private Limited U24100OR2018PTC028926 Bhubaneswar, Orissa, India
Apta Labs Private Limited U73200TG2021PTC148504 Rangareddy, Telangana, India
Bipha Bioscience Private Limited U73200KL2019PTC058729 Kottayam, Kerala, India
Raspa Pharma Private Limited U24297UP2020PTC132251 Lucknow, Uttar Pradesh, India
Navya Life Sciences Research Foundation U73100KA2011NPL060638 Hubli, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Varda Biotech Private Limited before audits and certifications: compliance score 63/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Varda Biotech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 30/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Varda Biotech Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 71/100, distress signals and MSME payment-delay disclosures - know whether Varda Biotech Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Varda Biotech Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Varda Biotech Private Limited an active company?

Varda Biotech Private Limited has MCA status “Active” with a compliance score of 63/100 (Moderate).

Is Varda Biotech Private Limited financially healthy?

Varda Biotech Private Limited has a Financial Health Score of 45/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Varda Biotech Private Limited?

Its overall Trust Score is 71/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Varda Biotech Private Limited?

Promoters hold a majority stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Varda Biotech Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Varda Biotech Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 63/100 (Moderate).

Is it risky to lend to Varda Biotech Private Limited?

Its Credit Risk Score is 30/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.